 Home > Medical News > Medicines Company News > Hisun Pharmaceutical: Linezolid tablets obtained drug registration certificate

Hisun Pharmaceutical: Linezolid tablets obtained drug registration certificate

 Last Update: 2021-07-06
 Source: Internet
 Author: User

Tags

food research supplements

aquatic development group

national refrigeration products

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 8, Hisun Pharmaceuticals stated that it had recently received the "Drug Registration Certificate" for linezolid tablets approved and issued by the National Medical Products Administration
.

Linezolid tablets are suitable for the treatment of sensitive strains of specific microorganisms: hospital-acquired pneumonia; community-acquired pneumonia; complicated skin and skin soft tissue infections, including diabetic foot infections without osteomyelitis; uncomplicated skin and skin soft tissue infections; vancomycin-resistant Enterococcus infections feces
.

The company's linezolid tablets were approved by the National Food and Drug Administration according to the new 4 categories, and they were deemed to have passed the consistency evaluation

Linezolid tablets by the original drugstrong research and development, at present, linezolid tablets major domestic manufacturers in Chongqing Winbond Pharmaceutical Co.
, Ltd.
, Jiangsu Stockhausen Pharmaceutical Group Co.
, Ltd.
and so on
.

After inquiring the IMS database, the global sales of linezolid tablets in 2019 were approximately US$267.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.